GlobeNewswire

Standard Lithium Completes Lithium Carbonate Crystallisation Pilot Prototype

Del

VANCOUVER, British Columbia, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLL) (OTCQX: STLHF) (FRA: S5L), is pleased to announce that the Company has completed the construction of the prototype pilot plant for its proprietary selective crystallisation process, and is currently commissioning the plant for operation.  The pilot prototype has been designed and fabricated in partnership with Saltworks Technologies Inc. and will be initially operated at their facility in Richmond, British Columbia, Canada.

The prototype pilot has been designed based on Standard Lithium’s proprietary process that selectively crystallises “battery-quality” lithium carbonate from concentrated lithium chloride solutions (see Standard Lithium’s previous news release dated 12th Sept regarding progress on the lithium extraction pilot plant that will produce the concentrated lithium chloride solutions).  To date, the Company’s testwork has been completed at laboratory scale, and has yielded high purity lithium carbonate material (>99.5% purity).  The newly constructed pilot prototype will operate on a semi-continuous basis, whereby the feed solution is periodically replenished, and the final high purity lithium carbonate is periodically removed.  The prototype is designed to process up to 100 L/day of inlet brine, and produce up to 1 kg/day of lithium carbonate.  Artificial Intelligence (AI) enabled high-speed, multi-image photo-microscopy and computer image recognition for crystal size and shape will be tested during the prototype, and will be fully integrated into the process control system for the subsequent full-scale pilot.

The prototype is considered to be a proof-of-concept for the proprietary process, and commissioning is currently underway at Saltworks.  It is expected that members of Standard Lithium’s Technical Advisory Committee and their staff will operate the prototype for 2-3 months.  If results are positive, Standard Lithium will commission and build the full-scale crystallisation pilot plant for future deployment at the Project site in southern Arkansas.

Dr. Andy Robinson, President and COO of Standard Lithium commented, “we’re very excited to have this prototype pilot plant built and commissioned, and we are very grateful to Saltworks Technologies Inc. for their knowledge, expertise and diligence in designing, fabricating and commissioning this prototype so quickly.  It’s our hope that we can demonstrate how sophisticated modern crystallisation technologies developed and transferred from the pharmaceuticals industry can be adapted for use in the modern world of high purity lithium chemicals.

Ben Sparrow, CEO & Chief Engineer of Saltworks commented, “Standard Lithium’s proprietary process showed compelling potential when we ran it through our in-house mass & energy balance computer models and detailed engineering.  This is why we put our best people on it and accelerated the build.  The next step is to dial-in their innovation and start making high grade lithium carbonate.  If Standard Lithium likes the work and results, we are ready to rapidly deliver a mobile fully continuous plant and support Standard Lithium to commercialise this high-potential technology.”

The Company also announces that it has reached an agreement with Native Ads, Inc. (“Native Ads”) pursuant to which the Company will increase the budget under the master services agreement entered into with Native Ads.  Native Ads provides the Company with comprehensive digital media marketing services.  The new budget will allocate a further $250,000 to these services, of which $187,500 will be allocated to digital advertising, paid distribution and media buying, and the balance will be allocated to content creation and consulting and management services.

For further information concerning the Company’s engagement with Native Ads, readers are encouraged to review the Company’s news release of 19th July 2018.  Neither Native Ads, nor any of its directors or officers, own any securities of the Company.

The Company also wishes to clarify that it did not proceed with the intended grant of 2,100,000 restricted share units (RSUs) as announced in its news release of 21st February, 2018.  The board of directors have ultimately elected not to implement a restricted share unit plan at this time, and will not be proceeding with the grant of RSUs.  

Quality Assurance
Ross Lewis, Professional Engineer (APEGBC#116613), is a qualified person as defined by NI 43-101, and has reviewed and approved the relevant technical information that forms the basis for this news release.  Mr. Lewis is a consultant to the Company.

About Standard Lithium Ltd.
The Company’s flagship project is located in southern Arkansas, where it is engaged in the testing and proving of the commercial viability of lithium extraction from over 150,000 acres of permitted brine operations utilising the Company’s proprietary selective extraction technology.  The Company is also pursuing the resource development of over 30,000 acres of separate brine leases located in southwestern Arkansas and approximately 45,000 acres of mineral leases located in the Mojave Desert in San Bernardino County, California.

Standard Lithium is listed on the TSX Venture under the trading symbol “SLL”; quoted on the OTCQX under the symbol “STLHF”; and on the Frankfurt Stock Exchange under the symbol “S5L”. Please visit the Company’s website at www.standardlithium.com.

For further information, contact Anthony Alvaro at (604) 240 4793

About Saltworks Technologies
Saltworks Technologies treats the toughest water.  Saltworks delivers intelligent industrial desalination and zero liquid discharge (ZLD) water treatment plants.  We reliably separate out the salt, so customers can focus on their core business (www.saltworkstech.com).

For further information, contact Sydney Juzenas at (604) 628 6508 x260.

On behalf of the Board,

Standard Lithium Ltd.
Robert Mintak, CEO & Director

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.  This news release may contain certain “Forward-Looking Statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. When used in this news release, the words “anticipate”, “believe”, “estimate”, “expect”, “target, “plan”, “forecast”, “may”, “schedule” and other similar words or expressions identify forward-looking statements or information.  These forward-looking statements or information may relate to future prices of commodities, accuracy of mineral or resource exploration activity, reserves or resources, regulatory or government requirements or approvals, the reliability of third party information, continued access to mineral properties or infrastructure, fluctuations in the market for lithium and its derivatives, changes in exploration costs and government regulation in Canada and the United States, and other factors or information.  Such statements represent the Company’s current views with respect to future events and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social risks, contingencies and uncertainties.  Many factors, both known and unknown, could cause results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements.  The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affections such statements and information other than as required by applicable laws, rules and regulations.

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

Bio-Fence announces a breakthrough in Food Safety18.1.2019 08:11Pressemelding

The company have successfully completed a field trial of its new anti-microbial coating technology. The trials demonstrated a significant reduction in bacterial contamination during sensitive food production processes ASHDOD, Israel, Jan. 18, 2019 (GLOBE NEWSWIRE) -- Bio-Fence innovating coating technology announced today the successful completion of an intensive field trial on its innovative anti-microbial technology Pentagon. The trial was held in "Milouoff" (http://www.milouoff.co.il), one of the largest Ready to Eat poultry production sites in Israel and demonstrated superior results for Bio-Fence technology compared to alternatives. According to Mrs. Shiran Davidi, QA manager at Milouoff: “Bio-Fence technology seems to have clear benefits over existing antimicrobial solution. It is safe, highly potent and rechargeable.” The trial involved monitoring the performance of an epoxy floor coated with Bio-Fence anti-microbial technology compared to either commercial Silver Ion coating an

ERYTECH Presents TRYbeCA-1 Trial-in-Progress Poster at the 2019 ASCO GI Annual Meeting18.1.2019 07:00Pressemelding

LYON, France and CAMBRIDGE, Mass., Jan. 18, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red blood cells, announced that a poster entitled “TRYbeCA-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441)” will be presented today at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting in San Francisco. The poster (Abstract # TPS471) will be available at www.erytech.com after presentation at the conference. In September 2018, the TRYbeCA-1 trial was initiated. The Trial-in-Progress poster will provide an update on the study progress with investigators sites that have been initiated in multiple countries and actively recruiting patients. The trial is planned to enroll approximately 500 patients with

Fossil Group Enters Agreement To Sell Select Smartwatch Technology To Google17.1.2019 18:30Pressemelding

Transaction Unlocks Growth Opportunities for Fossil Group’s Wearables Business RICHARDSON, Texas, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Today, Fossil Group (NASDAQ:FOSL) announced its plan to sell to Google for $40 million intellectual property (IP) related to a smartwatch technology currently under development by Fossil Group. As part of the transaction, a portion of Fossil Group’s research and development (R&D) team currently supporting the transferring IP will join Google. Fossil Group retains more than 200 R&D team members to focus on innovation and product development. The transaction showcases Fossil Group and Google’s shared investment in the wearables industry. In recent years, smartwatches have become Fossil Group’s fastest growing category. The company successfully developed and launched smartwatches across 14 of its owned and licensed brands. “Fossil Group has experienced significant success in its wearables business by focusing on product design and development informed by our

Calgon Carbon Corporation Announces Global Price Increase17.1.2019 17:16Pressemelding

Pittsburgh, PA, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Calgon Carbon Corporation today announced a global price increase, effective February 1, 2019, where contracts permit, on all activated carbon products and related equipment due to a continued escalation in raw material costs and transportation expenses. The increase is expected to range between 10-15%, depending on the specific product, raw material type, services provided, and global market dynamics. The primary raw materials used for producing activated carbon are coal, coconut shell, and wood, each of which has gone up in price. Additionally, costs associated with both operating manufacturing facilities and transporting materials have also escalated. “Calgon Carbon’s raw material costs have increased significantly. Despite every effort to offset these increases through continuous improvements, the recent rise in raw material costs has exceeded our efforts,” said Jim Coccagno, Chief Commercial Officer for Calgon Carbon Corporation. “

Taconic Biosciences’ Animals Complete Most Recent Mission to the International Space Station17.1.2019 15:29Pressemelding

RENSSELAER, N.Y., Jan. 17, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces the completion of a recent mission to the International Space Station. This project represents a collaboration between the International Space Station (ISS) National Lab, National Aeronautics and Space Administration (NASA), Bioserve Space Technologies with support from the Leidos Corporation, and Taconic. Taconic has participated in several spaceflight missions with NASA since 1985. Most recently, as part of the science and research investigation payloads supported by the SpaceX Commercial Resupply Services missions, Taconic prepared mice to live aboard the International Space Station for extended periods. Previous spaceflight studies demonstrated that mice undergo rapid loss of muscle and bone mass, resembling accelerated aging. Therefore, mice exposed to microgravity via spaceflight are a valuable model to understand and devel

MPP Global Bridges the Innovation Gap by Centralising Physical and Digital Subscriber Management and Billing in a Single Cloud Platform17.1.2019 12:29Pressemelding

WARRINGTON, UK, Jan. 17, 2019 (GLOBE NEWSWIRE) -- MPP Global, the technology company that delivers eSuite, the world’s smartest subscriber management & billing platform, announces the launch of pivotal new functionality which enables media organisations to seamlessly create and manage the sale of physical subscriptions. This positions eSuite as the complete physical and digital subscription management solution. The development of this industry-first functionality was borne out of the common challenge for publishers when managing multiple systems for deploying bundled print and digital subscriptions. This is inflexible for publishers and limits choice for their customers, restricting the ability to seamlessly create and offer digital and print subscription bundles. Despite increased consumer uptake of digital subscriptions, print still accounts for almost 90% of circulation revenues globally. To drive reader revenues successfully, publishers require functionality to execute complementar